FDA Inspection 1204620 — Amy Lightner MD

Amy Lightner MD — FEI 3026147808

The FDA completed an inspection of Amy Lightner MD on Apr 26, 2023 in Cleveland, OH. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 6 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Apr 26, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Cleveland, OH (United States)

Additional Details

Sponsor-Investigator (S-I)

Citations

IDCFRDescription
2272721 CFR 312.64(b)Safety Reports - Serious Events
2272821 CFR 312.64(b)Safety Reports - Non-Serious Events
748221 CFR 312.50General responsibilities of sponsors
753021 CFR 312.62(b)Case history records- inadequate or inadequate
755821 CFR 312.57(c)Record retention requirement
756021 CFR 312.60FD-1572, protocol compliance

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.